Summit Securities Group’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Summit Securities Group's ACLS Position: Q2 2026 in Review
Summit Securities Group increased its Axcelis (ACLS) stake by 72% in Q2 2026, buying an estimated $25.5K and bringing the position to 410 shares worth $77.7K. The position accounts for 0.01% of the portfolio, ranked #484.
Summit Securities Group first reported a position in ACLS in Q3 2014 and has held it in 5 quarters since. The position peaked at $93K in Q4 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Summit Securities Group held 410 shares of Axcelis worth $77.7K as of Q2 2026.
- Summit Securities Group bought 172 Axcelis shares in Q2 2026, an estimated $25.5K.
- Axcelis made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #484 holding.
- Summit Securities Group first reported a position in Axcelis in Q3 2014 and has held it in 5 quarters since.
- Summit Securities Group's Axcelis position peaked at $93K in Q4 2023.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.